Cryoglobulinaemia
- 2 August 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Reviews Disease Primers
- Vol. 4 (1), 11
- https://doi.org/10.1038/s41572-018-0009-4
Abstract
Cryoglobulinaemia refers to the serum presence of cryoglobulins, which are defined as immunoglobulins that precipitate at temperatures <37 °C. Type I cryoglobulinaemia consists of only one isotype or subclass of monoclonal immunoglobulin, whereas type II and type III are classified as mixed cryoglobulinaemia because they include immunoglobulin G (IgG) and IgM. Many lymphoproliferative, infectious and autoimmune disorders have been associated with mixed cryoglobulinaemia; however, hepatitis C virus (HCV) is the aetiologic agent in most patients. The underlying mechanism of the disorder is B cell lymphoproliferation and autoantibody production. Mixed cryoglobulinaemia can cause systemic vasculitis, with manifestations ranging from purpura, arthralgia and weakness to more serious lesions with skin ulcers, neurological and renal involvement. This Primer focuses on mixed cryoglobulinaemia, which has a variable course and a prognosis that is primarily influenced by vasculitis-associated multiorgan damage. In addition, the underlying associated disease in itself may cause considerable mortality and morbidity. Treatment of cryoglobulinaemic vasculitis should be modulated according to the underlying associated disease and the severity of organ involvement and relies on antiviral treatment (for HCV infection), immunosuppression and immunotherapy, particularly anti-CD20 B cell depletion therapies.Keywords
This publication has 142 references indexed in Scilit:
- Evidence-based focused review of management of hyperviscosity syndromeBlood, 2012
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitisArthritis & Rheumatism, 2011
- Treatment of rheumatoid arthritis in patients with concomitant chronic hepatitis C infectionTherapeutic Advances in Musculoskeletal Disease, 2011
- Preliminary classification criteria for the cryoglobulinaemic vasculitisAnnals Of The Rheumatic Diseases, 2011
- Complement receptor 2/CD21− human naive B cells contain mostly autoreactive unresponsive clonesBlood, 2010
- Hepatitis C virus–induced cryoglobulinemiaKidney International, 2009
- Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemiaBlood, 2008
- Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspectsPostgraduate Medical Journal, 2007
- Wirksamkeit von alpha-Interferon bei Patienten mit gemischter Kryoglobulinämie und chronischer HCV-InfektionInfection, 1993
- Deflazacort in the treatment of haematologic disordersEuropean Journal of Clinical Pharmacology, 1993